Table 1.
Clinical characteristics associated with overall survival of the patients
| Characteristics | n (%) | MST (mo) (95% CI) | P Log-rank test |
| Age (yr) (median: 59, range: 28-73) | |||
| < 59 | 37 (45.7) | 13.900 (8.075-19.725) | 0.610 |
| ≥ 59 | 44 (54.3) | 12.600 (6.595-18.605) | |
| Gender | |||
| Male | 55 (67.9) | 12.600 (7.674-17.526) | 0.384 |
| Female | 26 (32.1) | 15.300 (6.017-24.583) | |
| ECOG | |||
| 0-1 | 64 (79.0) | 14.300 (9.194-19.406) | 0.034 |
| 2 | 17 (21.0) | 9.800 (5.307-14.293) | |
| Lymph node | |||
| Negative | 13 (16.0) | 35.100 (5.695-64.505) | 0.004 |
| Positive | 68 (84.0) | 9.900 (7.480-12.320) | |
| Initial staging | |||
| III | 38 (46.9) | 17.800 (14.187-21.413) | 0.017 |
| IV | 43 (53.1) | 8.600 (6.157-11.043) | |
| Grading | |||
| G2 | 23 (28.4) | 14.500 (2.761-26.239) | 0.584 |
| G3 | 58 (71.6) | 12.600 (7.823-17.377) | |
| Site of tumor | |||
| Proximal stomach | 30 (37.0) | 10.300 (5.283-15.317) | 0.806 |
| Distal stomach | 44 (54.3) | 15.400 (9.380-21.420) | |
| Whole stomach | 7 (8.6) | 10.800 (4.439-17.161) |
MST: Median survival time; ECOG: Eastern Cooperative Oncology Group.